LLY
1,075.18
+0.27%↑
JNJ
207.23
+0.6%↑
ABBV
227.72
+0.26%↑
UNH
325.11
-0.71%↓
AZN
91.53
+0.2%↑
LLY
1,075.18
+0.27%↑
JNJ
207.23
+0.6%↑
ABBV
227.72
+0.26%↑
UNH
325.11
-0.71%↓
AZN
91.53
+0.2%↑
LLY
1,075.18
+0.27%↑
JNJ
207.23
+0.6%↑
ABBV
227.72
+0.26%↑
UNH
325.11
-0.71%↓
AZN
91.53
+0.2%↑
LLY
1,075.18
+0.27%↑
JNJ
207.23
+0.6%↑
ABBV
227.72
+0.26%↑
UNH
325.11
-0.71%↓
AZN
91.53
+0.2%↑
LLY
1,075.18
+0.27%↑
JNJ
207.23
+0.6%↑
ABBV
227.72
+0.26%↑
UNH
325.11
-0.71%↓
AZN
91.53
+0.2%↑
24h
Current
Min
14.24
Max
15.04
Income | 28M 8.2M |
|---|---|
Sales | 351K 351K |
P/E Sector Avg | 18.068 76.798 |
EPS | 0.94 |
Profit margin | 2,337.322 |
Employees | 103 |
EBITDA | 28M 9.3M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +50.38% upside |
Market Cap | 10M 144M |
|---|---|
Previous open | 16.91 |
Previous close | 14.49 |
By Acuity
28%
72%
72 / 374 Ranking in Healthcare
By Trading Central
Confidence
Bearish Evidence
N/A / 9.31 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
22 gru 2025, 23:54 UTC
Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form
DJ
Read
22 gru 2025, 19:08 UTC
Correction to Alphabet to Buy Intersect Article
DJ
Read
22 gru 2025, 17:21 UTC
Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update
DJ
Read
22 gru 2025, 16:46 UTC
Alphabet to Buy Intersect for $4.75 Billion in Cash
DJ
Read
22 gru 2025, 23:50 UTC
Nikkei May Decline as Yen Rebounds -- Market Talk
DJ
Read
22 gru 2025, 23:42 UTC
Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk
DJ
Read
22 gru 2025, 22:31 UTC
Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ
DJ
Read
22 gru 2025, 22:31 UTC
Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ
DJ
Read
22 gru 2025, 22:30 UTC
Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ
DJ
Read
22 gru 2025, 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
22 gru 2025, 21:50 UTC
Health Care Roundup: Market Talk
DJ
Read
22 gru 2025, 21:37 UTC
Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure
DJ
Read
22 gru 2025, 21:36 UTC
Capricorn to Pay A$500,000 Cash, A$4M in New Shares
DJ
Read
22 gru 2025, 21:35 UTC
Capricorn to Acquire Prospective Package From Tempest Minerals
DJ
Read
22 gru 2025, 21:35 UTC
Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M
DJ
Read
22 gru 2025, 20:54 UTC
Middle West Partners Buys Paul Stuart From Mitsui & Co.
DJ
Read
22 gru 2025, 20:52 UTC
HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY
DJ
Read
22 gru 2025, 20:09 UTC
U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk
DJ
Read
22 gru 2025, 19:56 UTC
Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk
DJ
Read
22 gru 2025, 19:49 UTC
A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com
DJ
Read
22 gru 2025, 19:23 UTC
Mexico's Inflation Seen Easing in Early December -- Market Talk
DJ
Read
22 gru 2025, 19:23 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
22 gru 2025, 19:02 UTC
Global Energy Roundup: Market Talk
DJ
Read
22 gru 2025, 19:02 UTC
Precious Metals Climb to New Heights -- Market Talk
DJ
Read
22 gru 2025, 18:45 UTC
Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk
DJ
Read
22 gru 2025, 18:30 UTC
Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk
DJ
Read
22 gru 2025, 18:23 UTC
What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com
DJ
Read
22 gru 2025, 17:20 UTC
Health Care Roundup: Market Talk
DJ
Read
22 gru 2025, 17:15 UTC
Global Commodities Roundup: Market Talk
DJ
Read
22 gru 2025, 17:06 UTC
Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 22 USD 50.38%
High 22 USD
Low 22 USD
Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Bearish Evidence
All events are bearish.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$